| |
 |
|
|
|
|
|
|
|
|
-
FDA Approves Once-Daily Mirapex ER For The Treatment Of Early Parkinson’s Disease
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson’s disease (PD). MIRAPEX ER is not indicated for the treatment of advanced PD.
Read more ...
-
US Anti-Migraine Drugs Market to Exceed $3.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a US and European report on Anti-Migraine Drugs. The US and European markets for anti-migraine drugs are projected to exceed $3.2 billion and $734 million, respectively, by 2015. There are a large number of drugs, both preventive and abortive, available in the US and European markets, but the number of those using these medicines are not as many as those suffering from this temporarily disabling condition.
Read more ...
-
DavisPTnetwork Partners with the Florida Physical Therapy Association to Provide Online Continuing Education
PTs and PTAs in Florida can now fulfill their continuing-education requirements with convenient and affordable online courses that are peer reviewed and state approved
Read more ...
-
Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery
Blue Cross and Blue Shield of Texas has designated Houston Northwest Medical Center as a Blue Distinction Center for Spine Surgery.
Read more ...
-
Talaris Advisors Attracts Veteran Team of Strategic Drug Development Managers
Biotech leaders enable Talaris’ capacity to deliver unprecedented, cross-functional expertise for all phases of drug development.
Read more ...
-
New Successful Treatment Improves Walking Post Stroke
A study published in the Journal of Geriatrics Association shows a new virtual reality device, the GaitAid, can help stroke patients learn to walk better.
Read more ...
-
Chiropractic Stroke Victims Optimistic that Board Will Issue Declaratory Ruling on Behalf of Patient Safety
Chiropractic Denials of Risk Compared to Decades Old Tobacco Industry Denials
Read more ...
-
Photometrics® to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting
Presentations to Highlight Technologies for Quantitative, Reproducible Imaging and Enhancing Fluorescence Correlation Spectroscopy Data
Read more ...
-
Two UCSF Scientists to Receive Prestigious Dementia Research Honor
Two UCSF scientists have been selected for the American Academy of Neurology’s prestigious Potamkin Prize, for their “outstanding achievements” in research on dementias.
Read more ...
-
February 28 is Rare Disease Day: Allsup commends SSA Plans to Expand Compassionate Allowance Program
Individuals suffering from rare diseases often face great difficulty in applying for Social Security disability benefits. Allsup applauds the SSA’s recent decision to expand its Compassionate Allowance program in an effort to provide benefits more quickly to eligible applicants. Tbe announcement comes as Allsup and other organizations work with the National Organization for Rare Disorders to observe Rare Disease Day, Feb. 28, to raise awareness of the need for more research and better access to diagnosis, treatment and other services.
Read more ...
 |
|
 |
|
|
|
|
|
